Michael J. Puzo’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-400
Closed -$271K 71
2025
Q4
$271K Hold
400
0.07% 64
2025
Q3
$256K Hold
400
0.07% 64
2025
Q2
$215K Buy
+400
New +$191K 0.06% 71
2024
Q4
Sell
-400
Closed -$202K 75
2024
Q3
$202K Buy
+400
New +$194K 0.05% 75
2024
Q2
Sell
-400
Closed -$216K 75
2024
Q1
$216K Hold
400
0.06% 75
2023
Q4
$222K Buy
+400
New +$188K 0.07% 72
2023
Q3
Sell
-550
Closed -$276K 78
2023
Q2
$276K Sell
550
-100
-15% -$47.9K 0.09% 70
2023
Q1
$325K Hold
650
0.11% 67
2022
Q4
$265K Hold
650
0.1% 67
2022
Q3
$212K Hold
650
0.08% 71
2022
Q2
$228K Sell
650
-100
-13% -$40.8K 0.08% 70
2022
Q1
$410K Sell
750
-50
-6% -$26.3K 0.12% 66
2021
Q4
$527K Hold
800
0.15% 63
2021
Q3
$498K Sell
800
-150
-16% -$101K 0.16% 60
2021
Q2
$600K Sell
950
-50
-5% -$27.6K 0.19% 57
2021
Q1
$489K Sell
1,000
-200
-17% -$100K 0.16% 60
2020
Q4
$600K Hold
1,200
0.2% 55
2020
Q3
$472K Sell
1,200
-100
-8% -$37K 0.17% 59
2020
Q2
$429K Hold
1,300
0.16% 59
2020
Q1
$315K Sell
1,300
-200
-13% -$52.2K 0.14% 64
2019
Q4
$392K Hold
1,500
0.14% 64
2019
Q3
$408K Hold
1,500
0.15% 63
2019
Q2
$413K Buy
+1,500
New +$370K 0.15% 63

Other funds holding IDXX

Michael J. Puzo's IDXX Position: Q1 2026 in Review

Michael J. Puzo sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 400 shares — an estimated $271K sold.

Michael J. Puzo first reported a position in IDXX in Q2 2019 and held it in 23 quarters. The position peaked at $600K in Q2 2021. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Michael J. Puzo reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
  • Michael J. Puzo sold 400 Idexx Laboratories shares in Q1 2026, an estimated $271K.
  • Michael J. Puzo first reported a position in Idexx Laboratories in Q2 2019 and held it in 23 quarters.
  • Michael J. Puzo's Idexx Laboratories position peaked at $600K in Q2 2021.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Michael J. Puzo's 13F filing for Q1 2026, filed 7 May 2026.